PRESS RELEASE DUBLIN,15 June, 2015/PRNewswire/ –Actavis plc announced that the business has used Allergan plc as its fresh global name and will begin trading today under a new symbol — AGN — after ringing The Opening Bell at the New York Stock Exchange. The business name change follows the acquisition of Allergan inMarch 2015and the acceptance of the name modification by Actavis shareholders onJune 5. The mix of Allergan and Actavis developed one of the world's top 10 pharmaceutical companies by income and a leader in a new industry model – Growth Pharma . Today is an exciting day time for Allergan and our 30,000 employees around the world who have helped us reach this unique moment, saidBrent Saunders, CEO and President of Allergan.

Through these important partnerships, the business will continue to bring to bear scientific excellence and rigor to provide leading products that improve individual outcomes. Solid Combined Global Leadership Team with Deep Experience over the Business The combined business's expanded senior management team is comprised of leaders from both Allergan and Actavis. It is structured to leverage the strong talent from both businesses to ensure that the new business capitalizes on its expanded global industrial footprint and the tested track record of Allergan's powerful and important item franchises critically, while maintaining Actavis' continuing dominance as a world leader in generics.